Millennium Management LLC sold $89k of FTH
owner at Sensei Biotherapeutics, Inc.. 3,250 shares at an average of $27.50, traded Mar 26, 2026, filed May 15, 2026.
Score components
- +12Role10% owner
- +9Trade size$89k at market
- 0Share of holdings soldSold 2.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -36.4%, 3m +58.3%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-062603, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | POpen-market purchase Common Stockindirect: See footnote | +778 | $27.23 | $21k | 131,370 | May 15, 2026 |
| Mar 26, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,327 | $27.95 | $37k | 131,370 | May 15, 2026 |
| Mar 26, 2026 | POpen-market purchase Common Stockindirect: See footnote | +2,601 | $28.85 | $75k | 131,370 | May 15, 2026 |
| Mar 26, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,025 | $29.98 | $31k | 131,370 | May 15, 2026 |
| Mar 26, 2026 | SOpen-market sale Common Stockindirect: See footnote | -583 | $26.88 | $16k | 131,370 | May 15, 2026 |
| Mar 26, 2026 | SOpen-market sale Common Stockindirect: See footnote | -1,274 | $28.69 | $37k | 131,370 | May 15, 2026 |
| Mar 27, 2026 | POpen-market purchase Common Stockindirect: See footnote | +10,643 | $26.29 | $280k | 142,360 | May 15, 2026 |
| Mar 27, 2026 | POpen-market purchase Common Stockindirect: See footnote | +4,384 | $27.28 | $120k | 142,360 | May 15, 2026 |
| Mar 27, 2026 | POpen-market purchase Common Stockindirect: See footnote | +294 | $28.13 | $8,270 | 142,360 | May 15, 2026 |
| Mar 27, 2026 | SOpen-market sale Common Stockindirect: See footnote | -469 | $26.77 | $13k | 142,360 | May 15, 2026 |
| Mar 27, 2026 | SOpen-market sale Common Stockindirect: See footnote | -36 | $27.37 | $985 | 142,360 | May 15, 2026 |
| Mar 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +2,992 | $25.08 | $75k | 145,678 | May 15, 2026 |
| Mar 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +4,995 | $25.99 | $130k | 145,678 | May 15, 2026 |
| Mar 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,176 | $26.70 | $31k | 145,678 | May 15, 2026 |
| Mar 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +370 | $27.68 | $10k | 145,678 | May 15, 2026 |
| Mar 30, 2026 | SOpen-market sale Common Stockindirect: See footnote | -518 | $25.85 | $13k | 145,678 | May 15, 2026 |
| Mar 30, 2026 | SOpen-market sale Common Stockindirect: See footnote | -370 | $27.68 | $10k | 145,678 | May 15, 2026 |
Related signals
Other insiders at Sensei Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 64Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $326k 13,634 shares | +41% | |
| 69Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $401k 15,641 shares | +90% | |
| 62Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $406k 17,413 shares | - | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Anand Kiran Parikh President and CEO | $55k 2,806 shares | +0% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc owner | $501k 25,000 shares | -16% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | James Peyer owner, other | $501k 25,000 shares | -16% | |
| 39Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $818k 30,585 shares | +23% | |
| 31Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $382k 12,180 shares | +8% | |
| 20Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $77k 2,741 shares | -2% | |
| 23Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $141k 4,215 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.